Caption Management’s CytomX Therapeutics CTMX Stock Holding History

Caption Management’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.23M	Buy	+900,000	New	+$4.57M	0.02%	583
2025 Q4	–	Sell	-249,900	Closed	-$797K	–	1658
2025 Q3	$797K	Buy	249,900 +174,900	+233%	+$394K	0.01%	1182
2025 Q2	$170K	Buy	+75,000	New	+$121K	﹤0.01%	1277

Other funds holding CTMX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caption Management's CTMX Position: Q1 2026 in Review

Caption Management opened a new position in CytomX Therapeutics (CTMX) in Q1 2026: 573,224 shares worth $2.69M. The stake represents 0.02% of the portfolio and ranks #735 among its holdings.

179 funds tracked by Wall St. Rank hold CTMX as of Q1 2026.

Caption Management held 573,224 shares of CytomX Therapeutics worth $2.69M as of Q1 2026.
CytomX Therapeutics was a new Caption Management position in Q1 2026.
CytomX Therapeutics made up 0.02% of Caption Management's portfolio in Q1 2026, its #735 holding.
179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.